Bespoke Extracts (BSPK) Share-based Compensation (QoQ) (2012 - 2025)
Bespoke Extracts (BSPK) Share-based Compensation (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 110.56% |
| Dec 31, 2024 | -158.78% |
| Sep 30, 2024 | -16.03% |
| Jun 30, 2024 | 12.63% |
| Mar 31, 2024 | -48.71% |
| Dec 31, 2023 | 1.03% |
| Sep 30, 2023 | 5.37% |
| Jun 30, 2023 | -0.10% |
| Mar 31, 2023 | -92.94% |
| Dec 31, 2022 | 667.20% |
| Sep 30, 2022 | -75.90% |
| Jun 30, 2022 | -2.66% |
| Feb 28, 2021 | -149.33% |
| Nov 30, 2018 | 103.40% |
| Aug 31, 2018 | -268.54% |
| May 31, 2018 | 14.09% |
| Feb 28, 2018 | 8,394.13% |
| Nov 30, 2017 | -98.20% |
| May 31, 2012 | -86.36% |
| Feb 29, 2012 | 633.33% |